ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 651,40
0,25%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Merck & Co Inc (0QAH)

  7. Merck & Co Inc (0QAH) Actualités

0QAH

Merck & (0QAH)

Merck & Co Inc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0QAH
DateHeureSourceTitreSymboleSociété
29/05/202415h22Alliance NewsAlliance NewsMerck & Co enhances ophthalmology portfolio with EyeBio acquisitionLSE:0QAHMerck & Co Inc
25/04/202413h13Alliance NewsAlliance NewsMerck & Co raises annual outlook thanks to first quarter boostLSE:0QAHMerck & Co Inc
15/03/202416h23Alliance NewsAlliance NewsIN BRIEF: Merck hails positive data on cervical cancer drug, KeytrudaLSE:0QAHMerck & Co Inc
20/02/202422h15Alliance NewsAlliance NewsMerck and Astellas drugs get priority review in US and JapanLSE:0QAHMerck & Co Inc
01/02/202413h57Alliance NewsAlliance NewsTOP NEWS: Merck books 2023 growth despite gefapixant rejection hitLSE:0QAHMerck & Co Inc
19/01/202412h29Alliance NewsAlliance NewsIN BRIEF: Arix Bioscience eyes USD19 million return from Harpoon saleLSE:0QAHMerck & Co Inc
08/01/202415h20Alliance NewsAlliance NewsMerck to buy Harpoon Therapeutics for about USD680 millionLSE:0QAHMerck & Co Inc
18/12/202312h04Alliance NewsAlliance NewsAstellas, Merck, Pfizer celebrate US approval for Keytruda plus PadcevLSE:0QAHMerck & Co Inc
15/12/202309h41Alliance NewsAlliance NewsMerck gets US FDA nod for Welireg, as trial with Moderna bears fruitLSE:0QAHMerck & Co Inc
11/12/202318h56Alliance NewsAlliance NewsMerck reports mixed updates for cancer treatment, KeytrudaLSE:0QAHMerck & Co Inc
26/10/202313h17Alliance NewsAlliance NewsTOP NEWS: Merck hails Daiichi Sankyo partnership but will take chargeLSE:0QAHMerck & Co Inc
20/10/202307h06Alliance NewsAlliance NewsTOP NEWS: Daiichi Sankyo soars on USD22 billion Merck cancer drug dealLSE:0QAHMerck & Co Inc
03/10/202318h00Alliance NewsAlliance NewsDrugmakers agree to US government price talks amid pushbackLSE:0QAHMerck & Co Inc
24/08/202317h24Alliance NewsAlliance NewsUPDATE: AstraZeneca, Merck & Co say Lynparza approved in JapanLSE:0QAHMerck & Co Inc
01/08/202313h49Alliance NewsAlliance NewsMerck & Co second quarter revenue up; profit falls acquisition costsLSE:0QAHMerck & Co Inc
16/06/202314h09Alliance NewsAlliance NewsMerck says latest trial data shows Keytruda meets survival endpointLSE:0QAHMerck & Co Inc
01/06/202314h44Alliance NewsAlliance NewsMerck and Astra's Lynparza prostate cancer treatment gets US approvalLSE:0QAHMerck & Co Inc
01/05/202313h35Alliance NewsAlliance NewsAstraZeneca "disappointed" with US ODAC's guidance on LynparzaLSE:0QAHMerck & Co Inc
27/04/202313h49Alliance NewsAlliance NewsMerck & Co beats on first-quarter revenue and hails "advancements"LSE:0QAHMerck & Co Inc
10/03/202313h31Alliance NewsAlliance NewsMerck's Keytruda combination sees positive results in cancer trialLSE:0QAHMerck & Co Inc
02/03/202318h20Alliance NewsAlliance NewsUS FDA to discuss AstraZeneca and Merck's Lynparza cancer drug comboLSE:0QAHMerck & Co Inc
24/02/202313h48Alliance NewsAlliance NewsIN BRIEF: EU refuses marketing recommendation for Merck's LagevrioLSE:0QAHMerck & Co Inc
02/02/202314h08Alliance NewsAlliance NewsTOP NEWS: Merck & Co annual net profit up but drops in fourth-quarterLSE:0QAHMerck & Co Inc
30/01/202317h35Alliance NewsAlliance NewsDaiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatmentLSE:0QAHMerck & Co Inc
21/12/202210h16Alliance NewsAlliance NewsAstraZeneca wins two new approvals in EU for cancer drugsLSE:0QAHMerck & Co Inc
20/12/202219h09Alliance NewsAlliance NewsFDA accepts Astellas, Seagen and Merck's combo for priority reviewLSE:0QAHMerck & Co Inc
15/12/202209h37Alliance NewsAlliance NewsAstraZeneca and Merck receive US FDA extension for Lynparza reviewLSE:0QAHMerck & Co Inc
22/11/202218h18Alliance NewsAlliance NewsIN BRIEF: Merck's Keytruda sees positive topline results in trialLSE:0QAHMerck & Co Inc
21/11/202213h53Alliance NewsAlliance NewsMerck buys biopharmaceutical firm Imago BioSciences for USD1.4 billionLSE:0QAHMerck & Co Inc
27/10/202215h29Alliance NewsAlliance NewsTOP NEWS: Merck & Co 3rd-quarter sales up; profit slips as costs riseLSE:0QAHMerck & Co Inc
 Showing the most relevant articles for your search:LSE:0QAH

Dernières Valeurs Consultées

TG
AA2
AMADA
CSE
NORD
Nordique Resources
TG
HPHA
Heidelberg Pharma
LSE
77DU
Eq.asa 26
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés